← FDA Drug Approvals (Drugs@FDA)
THIOTEPA
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2021-12-08
Drug application
- FDA Application #
ANDA211831- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- THIOTEPA
- Generic name
- Thiotepa
- Active ingredients
- THIOTEPA
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- REGCON HOLDINGS
- First approval
- 2021-12-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown